PALI 3 (Invega 3 mg)

Generic Name: paliperidone

Pill imprint PALI 3 has been identified as Invega 3 mg.

Invega is used in the treatment of schizoaffective disorder; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Invega 3 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for PALI 3

Invega 3 mg PALI 3  Front
Invega 3 mg PALI 3  Back
Invega 3 mg PALI 3
Invega
Generic Name:
paliperidone
Imprint:
PALI 3
Strength:
3 mg
Color:
White
Size:
11.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Atypical antipsychotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Janssen Pharmaceuticals
National Drug Code (NDC):
50458-0550
Inactive Ingredients:
carnauba wax
cellulose acetate
polyethylene glycol
propylene glycol
povidone
sodium chloride
stearic acid
butylated hydroxytoluene
hypromelloses
titanium dioxide
ferrosoferric oxide
triacetin
lactose monohydrate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)